|
시장보고서
상품코드
1972947
소매 약국 시장 : 시장 인사이트, 경쟁 구도 및 시장 예측(2033년)Retail Pharmacy Market Insights, Competitive Landscape, and Market Forecast - 2033 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계 소매 약국 시장은 의료에 대한 인식 증가, 만성질환 증가, 자가치료 습관의 확산 등을 배경으로 큰 변화의 시기를 맞이하고 있습니다. 예측에 따르면, 시장 규모는 2026년 6억 8,680만 달러에 달하고, 2033년까지 11억 2,820만 달러로 확대될 것으로 예상되며, 예측 기간 동안 6.7%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 이러한 성장은 소매 약국이 의료 서비스와 환자를 연결하고 필수 의약품, 건강 제품 및 관련 의료 서비스에 쉽게 접근할 수 있도록 하는 데 있어 소매 약국이 중요한 역할을 하고 있음을 입증합니다.
시장 개요
소매 약국의 업무 범위는 기존의 처방전 조제를 훨씬 뛰어넘어 확대되고 있습니다. 현대의 약국에서는 일반의약품(OTC 의약품), 건강보조식품, 진단 도구, 건강증진 솔루션 등 다양한 제품을 제공합니다. 또한, 환자 교육 및 전문 상담 서비스도 제공하여 소비자의 신뢰와 참여를 강화하는 데 기여하고 있습니다. 자동 조제 시스템, 모바일 애플리케이션, 온라인 약국 플랫폼 등의 기술 통합을 통해 효율성을 높이고 고객 경험을 개선하고 있습니다.
소매 약국 서비스에 대한 수요 증가는 특히 선진국의 고령화, 신흥국의 의료비 증가와 같은 인구 통계학적 변화와 밀접한 관련이 있습니다. 당뇨병, 심혈관 질환, 고혈압과 같은 만성질환의 유병률 증가는 의약품 및 건강관리 솔루션에 대한 지속적인 수요를 견인하고 있습니다. 또한, 의료 접근성 증진, 보험 적용 범위 확대, 제네릭 의약품의 보급을 촉진하는 정부 지원 정책이 시장 확대에 긍정적인 영향을 미치고 있습니다.
주요 시장 성장 촉진요인
소매 약국 시장의 성장을 가속하는 요인은 다음과 같습니다.
- 1. 만성질환 부담 증가: 장기적인 질병 확산으로 인해 처방약과 건강제품에 대한 정기적인 접근에 대한 지속적인 수요가 발생하고 있습니다. 소매 약국은 이러한 수요를 효율적으로 충족시키는 핵심적인 역할을 담당하고 있습니다.
- 2. 제네릭 및 OTC 의약품의 성장: 제네릭 의약품의 채택은 브랜드 의약품을 대체할 수 있는 비용 효율적인 대안을 제공하고, 저렴한 가격을 실현하고 있습니다. OTC 의약품은 소비자들이 경미한 건강 문제를 편리하게 관리할 수 있게 해줍니다.
- 3. 기술 혁신 : 온라인 약국 플랫폼, 모바일 건강 앱, 디지털 처방전 관리 도구는 환자의 접근성, 편의성, 안전성을 향상시키고 있습니다.
- 4. 정부 지원 및 의료정책: 인센티브, 상환제도, 약국 인프라 구축에 대한 지원으로 서비스 제공 범위 확대 및 질적 향상을 실현하고 있습니다.
- 5. 소비자의 편의성 선호: 현대 소비자는 처방전, 건강 제품, 웰빙 솔루션을 한 곳에서 제공하는 소매 약국의 원스톱 쇼핑 모델을 선호합니다.
새로운 비즈니스 기회
소매 약국 시장에는 사업 성장과 혁신을 위한 여러 가지 길이 열려 있습니다.
- 디지털 및 옴니채널 확장: 온라인과 오프라인 서비스, 택배, 원격 의료 솔루션을 통합하여 보다 광범위한 고객층에 대한 접근성과 참여도를 높일 수 있습니다.
- 맞춤형 건강 서비스: 전문 건강검진, 예방접종 프로그램, 복약지도 제공은 기존의 소매 서비스보다 더 많은 부가 가치를 제공할 수 있습니다.
- 신흥지역 시장 진출: 아시아태평양, 라틴아메리카, 중동은 의료 인프라의 정비와 가처분 소득 증가로 높은 성장 잠재력을 가지고 있습니다.
- 개인 브랜드 및 브랜드 건강 제품: 자체 비타민제, 건강보조식품, 건강제품을 개발하여 브랜드 아이덴티티를 강화하고 수익원을 다각화할 수 있습니다.
지역별 전망
- 북미: 성숙한 약국 체인, 높은 의료비 지출, 디지털 약국 솔루션의 보급으로 이 지역은 선도적 지위를 유지하고 있습니다. 특히 미국에서는 체인 약국과 전자상거래 플랫폼으로 인해 견조한 성장세를 보이고 있습니다.
- 유럽: 탄탄한 의료 인프라, 상환제도, 만성질환 관리 정책이 성장을 뒷받침하고 있습니다. 독일, 프랑스, 영국 등의 국가에서는 이미 잘 구축된 약국 네트워크를 갖추고 있습니다.
- 아시아태평양: 중국, 인도, 일본 등의 국가에서 급속한 도시화, 의료에 대한 인식 증가, 저렴한 의약품에 대한 접근성을 촉진하는 정부 프로그램이 성장을 주도하고 있습니다.
- 라틴아메리카: 소매 네트워크의 확대와 비용 효율적인 제네릭 의약품의 채택이 시장 발전을 주도하고 있으며, 브라질과 멕시코가 성장 궤도를 주도하고 있습니다.
- 중동 및 아프리카: 아직 개발 단계에 있지만, 의료 투자 증가, 공급망 개선, 소비자의 건강 의식 향상으로 인해 꾸준한 성장세를 보이고 있습니다.
주요 진출 기업
소매 약국 시장은 경쟁이 치열하며, 여러 세계 기업들이 광범위한 소매 네트워크, 디지털 플랫폼, 부가 가치 서비스를 활용하고 있습니다.
- Walgreens Boots Alliance Inc.
- CVS Health Corporation
- Rite Aid Corporation
- Walmart Inc.
- Wal-Mart de Mexico, S.A.B. de C.V.
- Costco Wholesale Corporation
- Kroger Co.
- McKesson Corporation
- Cardinal Health Inc.
- AmerisourceBergen Corporation
- Albertsons Companies
- Dirk Rossmann GmbH
- The Jean Coutu Group(PJC) Inc.
- Loblaws Inc.
- Ahold Delhaize
이들 기업은 시장 지위를 강화하고, 지리적 범위를 확장하고, 서비스 제공을 강화하기 위해 전략적 인수, 제휴 및 기술 혁신을 지속적으로 추구하고 있습니다.
시장 세분화
유형별
- 제네릭 의약품
- 일반의약품(OTC 의약품)
- 특허 의약품 또는 브랜드 의약품
용도별
- 의약품 소매
- 건강 제품 소매
- 의료기기 소매
용도별
- 소비자/환자
- 의료기관
- 전통 의료 종사자
판매 채널별
- 온라인
- 오프라인
지역별
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
목차
제1장 주요 요약
제2장 시장 개요
- 시장 정의와 세분화
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 시장 기회
- 밸류체인 분석
- COVID-19의 영향 분석
- Porter의 Five Forces 분석
- 러시아·우크라이나 분쟁의 영향
- PESTLE 분석
- 규제 분석
- 가격 동향 분석
- 현재 가격과 향후 예측, 2025년-2033년
- 가격 영향요인
제3장 세계의 소매 약국 시장 전망, 2020년-2033년
- 세계의 소매 약국 시장 전망, 유형별, 금액(10억 달러), 2020년-2033년
- 제네릭 의약품
- 시판약(OTC 의약품)
- 특허 의약품 또는 브랜드 의약품
- 세계의 소매 약국 시장 전망, 용도별, 금액(10억 달러), 2020년-2033년
- 의약품 소매
- 건강식품 소매
- 기기 소매
- 세계의 소매 약국 시장 전망, 최종 용도별, 금액(10억 달러), 2020년-2033년
- 소비자/환자
- 의료시설
- 전통 의학 실천자
- 세계의 소매 약국 시장 전망, 채널별, 금액(10억 달러), 2020년-2033년
- 온라인
- 오프라인
- 세계의 소매 약국 시장 전망, 지역별, 금액(10억 달러), 2020년-2033년
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
제4장 북미 소매 약국 시장 전망, 2020년-2033년
제5장 유럽 소매 약국 시장 전망, 2020년-2033년
제6장 아시아태평양 소매 약국 시장 전망, 2020년-2033년
제7장 라틴아메리카 소매 약국 시장 전망, 2020년-2033년
제8장 중동 및 아프리카 소매 약국 시장 전망, 2020년-2033년
제9장 경쟁 구도
- 기업대 부문 히트맵
- 기업의 시장 점유율 분석, 2025년
- 경쟁 대시보드
- 기업 개요
- Walgreens Boots Alliance Inc.
- CVS Health Corporation
- Rite Aid Corporation
- Walmart Inc.
- Costco Wholesale Corporation
- Kroger Co.
- McKesson Corporation
- Cardinal Health Inc.
- AmerisourceBergen Corporation
- Albertsons Companies
제10장 부록
LSH 26.04.01The global retail pharmacy market is undergoing significant transformation, fueled by rising healthcare awareness, increasing prevalence of chronic diseases, and the growing adoption of self-medication practices. Forecasts indicate that the market is expected to reach $686.8 million in 2026, expanding to $1,128.2 million by 2033, reflecting a CAGR of 6.7% over the forecast period. This growth underscores the crucial role that retail pharmacies play in connecting healthcare services with patients, providing easy access to essential medications, wellness products, and related healthcare services.
Market Overview
The retail pharmacy landscape has expanded well beyond conventional prescription dispensing. Today's pharmacies offer a wide array of products, including over-the-counter (OTC) medications, health supplements, diagnostic tools, and wellness solutions. They also provide patient education and professional consultation services, contributing to stronger consumer trust and engagement. Technological integration, such as automated dispensing systems, mobile applications, and online pharmacy platforms, is enhancing efficiency and improving the customer experience.
The growing demand for retail pharmacy services is closely tied to demographic shifts, particularly aging populations in developed regions and increasing healthcare expenditure in emerging economies. The rising prevalence of chronic illnesses like diabetes, cardiovascular conditions, and hypertension is driving consistent demand for medications and health management solutions. Additionally, supportive government policies promoting healthcare accessibility, insurance coverage, and generic medication adoption are positively impacting market expansion.
Key Market Drivers
Several factors are propelling the growth of the retail pharmacy market:
- 1. Increasing Chronic Disease Burden: The prevalence of long-term conditions has created sustained demand for regular access to prescription medications and wellness products. Retail pharmacies are central to meeting this demand efficiently.
- 2. Growth of Generic and OTC Medications: The adoption of generic drugs provides cost-effective alternatives to branded medications, increasing affordability. OTC medications allow consumers to manage minor health concerns conveniently.
- 3. Technological Advancements: Online pharmacy platforms, mobile health apps, and digital prescription management tools are improving patient access, convenience, and safety.
- 4. Government Support and Healthcare Policies: Incentives, reimbursement schemes, and support for pharmacy infrastructure development are enabling wider reach and better service delivery.
- 5. Consumer Preference for Convenience: Modern consumers prefer the one-stop-shop model offered by retail pharmacies, which combines prescriptions, health products, and wellness solutions in a single location.
Emerging Business Opportunities
The retail pharmacy market presents several avenues for business growth and innovation:
- Digital and Omnichannel Expansion: Integrating online and offline services, home delivery, and telemedicine solutions helps companies reach a broader customer base and improve engagement.
- Personalized Health Services: Offering specialized health checks, vaccination programs, and medication counseling can provide added value beyond traditional retail offerings.
- Market Penetration in Emerging Regions: Asia Pacific, Latin America, and the Middle East present high growth potential due to rising healthcare infrastructure and increasing disposable incomes.
- Private Label and Branded Health Products: Developing proprietary vitamins, supplements, and wellness products can strengthen brand identity and diversify revenue streams.
Regional Outlook
- North America: The region maintains a leading position, driven by mature pharmacy chains, high healthcare expenditure, and widespread adoption of digital pharmacy solutions. The United States, in particular, shows robust growth due to chain pharmacies and e-commerce platforms.
- Europe: Growth in Europe is supported by strong healthcare infrastructure, reimbursement programs, and chronic disease management initiatives. Countries such as Germany, France, and the UK host well-established pharmacy networks.
- Asia Pacific: Rapid urbanization, increasing healthcare awareness, and government programs promoting affordable medicine access are fueling growth in countries like China, India, and Japan.
- Latin America: Expansion of retail networks and adoption of cost-effective generic medications drive market development, with Brazil and Mexico leading the growth trajectory.
- Middle East & Africa: Although still emerging, this region is experiencing steady growth due to increasing healthcare investments, improving supply chains, and rising consumer health consciousness.
Leading Players
The retail pharmacy market is highly competitive, with several global players leveraging extensive retail networks, digital platforms, and value-added services:
- Walgreens Boots Alliance Inc.
- CVS Health Corporation
- Rite Aid Corporation
- Walmart Inc.
- Wal-Mart de Mexico, S.A.B. de C.V.
- Costco Wholesale Corporation
- Kroger Co.
- McKesson Corporation
- Cardinal Health Inc.
- AmerisourceBergen Corporation
- Albertsons Companies
- Dirk Rossmann GmbH
- The Jean Coutu Group (PJC) Inc.
- Loblaws Inc.
- Ahold Delhaize
These companies continue to pursue strategic acquisitions, partnerships, and technological innovations to strengthen market position, expand geographic reach, and enhance service offerings.
Market Segmentation
By Type
- Generic Medications
- Over the Counter (OTC) Medications
- Patented or Brand-name Medications
By Application
- Drug Retail
- Health Products Retail
- Equipment Retail
By End Use
- Consumer/Patients
- Healthcare Facilities
- Traditional Medicine Practitioners
By Channel
- Online
- Offline
By Geographic Coverage
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Retail Pharmacy Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Five Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Retail Pharmacy Market Outlook, 2020-2033
- 3.1. Global Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 3.1.1. Generic Medications
- 3.1.2. Over the Counter (OTC) Medications
- 3.1.3. Patented or Brand-name Medications
- 3.2. Global Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 3.2.1. Drug Retail
- 3.2.2. Health Products Retail
- 3.2.3. Equipment Retail
- 3.3. Global Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2020-2033
- 3.3.1. Consumer/Patients
- 3.3.2. Healthcare Facilities
- 3.3.3. Traditional Medicine Practitioners
- 3.4. Global Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2020-2033
- 3.4.1. Online
- 3.4.2. Offline
- 3.5. Global Retail Pharmacy Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa
4. North America Retail Pharmacy Market Outlook, 2020-2033
- 4.1. North America Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 4.1.1. Generic Medications
- 4.1.2. Over the Counter (OTC) Medications
- 4.1.3. Patented or Brand-name Medications
- 4.2. North America Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 4.2.1. Drug Retail
- 4.2.2. Health Products Retail
- 4.2.3. Equipment Retail
- 4.3. North America Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2020-2033
- 4.3.1. Consumer/Patients
- 4.3.2. Healthcare Facilities
- 4.3.3. Traditional Medicine Practitioners
- 4.4. North America Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2020-2033
- 4.4.1. Online
- 4.4.2. Offline
- 4.5. North America Retail Pharmacy Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.5.1. U.S. Retail Pharmacy Market Outlook, by Type, 2020-2033
- 4.5.2. U.S. Retail Pharmacy Market Outlook, by Application, 2020-2033
- 4.5.3. U.S. Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 4.5.4. U.S. Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 4.5.5. Canada Retail Pharmacy Market Outlook, by Type, 2020-2033
- 4.5.6. Canada Retail Pharmacy Market Outlook, by Application, 2020-2033
- 4.5.7. Canada Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 4.5.8. Canada Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Retail Pharmacy Market Outlook, 2020-2033
- 5.1. Europe Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 5.1.1. Generic Medications
- 5.1.2. Over the Counter (OTC) Medications
- 5.1.3. Patented or Brand-name Medications
- 5.2. Europe Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 5.2.1. Drug Retail
- 5.2.2. Health Products Retail
- 5.2.3. Equipment Retail
- 5.3. Europe Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2020-2033
- 5.3.1. Consumer/Patients
- 5.3.2. Healthcare Facilities
- 5.3.3. Traditional Medicine Practitioners
- 5.4. Europe Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2020-2033
- 5.4.1. Online
- 5.4.2. Offline
- 5.5. Europe Retail Pharmacy Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.5.1. Germany Retail Pharmacy Market Outlook, by Type, 2020-2033
- 5.5.2. Germany Retail Pharmacy Market Outlook, by Application, 2020-2033
- 5.5.3. Germany Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 5.5.4. Germany Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 5.5.5. Italy Retail Pharmacy Market Outlook, by Type, 2020-2033
- 5.5.6. Italy Retail Pharmacy Market Outlook, by Application, 2020-2033
- 5.5.7. Italy Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 5.5.8. Italy Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 5.5.9. France Retail Pharmacy Market Outlook, by Type, 2020-2033
- 5.5.10. France Retail Pharmacy Market Outlook, by Application, 2020-2033
- 5.5.11. France Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 5.5.12. France Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 5.5.13. U.K. Retail Pharmacy Market Outlook, by Type, 2020-2033
- 5.5.14. U.K. Retail Pharmacy Market Outlook, by Application, 2020-2033
- 5.5.15. U.K. Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 5.5.16. U.K. Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 5.5.17. Spain Retail Pharmacy Market Outlook, by Type, 2020-2033
- 5.5.18. Spain Retail Pharmacy Market Outlook, by Application, 2020-2033
- 5.5.19. Spain Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 5.5.20. Spain Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 5.5.21. Russia Retail Pharmacy Market Outlook, by Type, 2020-2033
- 5.5.22. Russia Retail Pharmacy Market Outlook, by Application, 2020-2033
- 5.5.23. Russia Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 5.5.24. Russia Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 5.5.25. Rest of Europe Retail Pharmacy Market Outlook, by Type, 2020-2033
- 5.5.26. Rest of Europe Retail Pharmacy Market Outlook, by Application, 2020-2033
- 5.5.27. Rest of Europe Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 5.5.28. Rest of Europe Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Retail Pharmacy Market Outlook, 2020-2033
- 6.1. Asia Pacific Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 6.1.1. Generic Medications
- 6.1.2. Over the Counter (OTC) Medications
- 6.1.3. Patented or Brand-name Medications
- 6.2. Asia Pacific Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 6.2.1. Drug Retail
- 6.2.2. Health Products Retail
- 6.2.3. Equipment Retail
- 6.3. Asia Pacific Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2020-2033
- 6.3.1. Consumer/Patients
- 6.3.2. Healthcare Facilities
- 6.3.3. Traditional Medicine Practitioners
- 6.4. Asia Pacific Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2020-2033
- 6.4.1. Online
- 6.4.2. Offline
- 6.5. Asia Pacific Retail Pharmacy Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.5.1. China Retail Pharmacy Market Outlook, by Type, 2020-2033
- 6.5.2. China Retail Pharmacy Market Outlook, by Application, 2020-2033
- 6.5.3. China Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 6.5.4. China Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 6.5.5. Japan Retail Pharmacy Market Outlook, by Type, 2020-2033
- 6.5.6. Japan Retail Pharmacy Market Outlook, by Application, 2020-2033
- 6.5.7. Japan Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 6.5.8. Japan Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 6.5.9. South Korea Retail Pharmacy Market Outlook, by Type, 2020-2033
- 6.5.10. South Korea Retail Pharmacy Market Outlook, by Application, 2020-2033
- 6.5.11. South Korea Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 6.5.12. South Korea Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 6.5.13. India Retail Pharmacy Market Outlook, by Type, 2020-2033
- 6.5.14. India Retail Pharmacy Market Outlook, by Application, 2020-2033
- 6.5.15. India Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 6.5.16. India Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 6.5.17. Southeast Asia Retail Pharmacy Market Outlook, by Type, 2020-2033
- 6.5.18. Southeast Asia Retail Pharmacy Market Outlook, by Application, 2020-2033
- 6.5.19. Southeast Asia Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 6.5.20. Southeast Asia Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 6.5.21. Rest of SAO Retail Pharmacy Market Outlook, by Type, 2020-2033
- 6.5.22. Rest of SAO Retail Pharmacy Market Outlook, by Application, 2020-2033
- 6.5.23. Rest of SAO Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 6.5.24. Rest of SAO Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Retail Pharmacy Market Outlook, 2020-2033
- 7.1. Latin America Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 7.1.1. Generic Medications
- 7.1.2. Over the Counter (OTC) Medications
- 7.1.3. Patented or Brand-name Medications
- 7.2. Latin America Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 7.2.1. Drug Retail
- 7.2.2. Health Products Retail
- 7.2.3. Equipment Retail
- 7.3. Latin America Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2020-2033
- 7.3.1. Consumer/Patients
- 7.3.2. Healthcare Facilities
- 7.3.3. Traditional Medicine Practitioners
- 7.4. Latin America Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2020-2033
- 7.4.1. Online
- 7.4.2. Offline
- 7.5. Latin America Retail Pharmacy Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.5.1. Brazil Retail Pharmacy Market Outlook, by Type, 2020-2033
- 7.5.2. Brazil Retail Pharmacy Market Outlook, by Application, 2020-2033
- 7.5.3. Brazil Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 7.5.4. Brazil Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 7.5.5. Mexico Retail Pharmacy Market Outlook, by Type, 2020-2033
- 7.5.6. Mexico Retail Pharmacy Market Outlook, by Application, 2020-2033
- 7.5.7. Mexico Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 7.5.8. Mexico Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 7.5.9. Argentina Retail Pharmacy Market Outlook, by Type, 2020-2033
- 7.5.10. Argentina Retail Pharmacy Market Outlook, by Application, 2020-2033
- 7.5.11. Argentina Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 7.5.12. Argentina Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 7.5.13. Rest of LATAM Retail Pharmacy Market Outlook, by Type, 2020-2033
- 7.5.14. Rest of LATAM Retail Pharmacy Market Outlook, by Application, 2020-2033
- 7.5.15. Rest of LATAM Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 7.5.16. Rest of LATAM Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Retail Pharmacy Market Outlook, 2020-2033
- 8.1. Middle East & Africa Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 8.1.1. Generic Medications
- 8.1.2. Over the Counter (OTC) Medications
- 8.1.3. Patented or Brand-name Medications
- 8.2. Middle East & Africa Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 8.2.1. Drug Retail
- 8.2.2. Health Products Retail
- 8.2.3. Equipment Retail
- 8.3. Middle East & Africa Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2020-2033
- 8.3.1. Consumer/Patients
- 8.3.2. Healthcare Facilities
- 8.3.3. Traditional Medicine Practitioners
- 8.4. Middle East & Africa Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2020-2033
- 8.4.1. Online
- 8.4.2. Offline
- 8.5. Middle East & Africa Retail Pharmacy Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.5.1. GCC Retail Pharmacy Market Outlook, by Type, 2020-2033
- 8.5.2. GCC Retail Pharmacy Market Outlook, by Application, 2020-2033
- 8.5.3. GCC Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 8.5.4. GCC Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 8.5.5. South Africa Retail Pharmacy Market Outlook, by Type, 2020-2033
- 8.5.6. South Africa Retail Pharmacy Market Outlook, by Application, 2020-2033
- 8.5.7. South Africa Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 8.5.8. South Africa Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 8.5.9. Egypt Retail Pharmacy Market Outlook, by Type, 2020-2033
- 8.5.10. Egypt Retail Pharmacy Market Outlook, by Application, 2020-2033
- 8.5.11. Egypt Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 8.5.12. Egypt Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 8.5.13. Nigeria Retail Pharmacy Market Outlook, by Type, 2020-2033
- 8.5.14. Nigeria Retail Pharmacy Market Outlook, by Application, 2020-2033
- 8.5.15. Nigeria Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 8.5.16. Nigeria Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 8.5.17. Rest of Middle East Retail Pharmacy Market Outlook, by Type, 2020-2033
- 8.5.18. Rest of Middle East Retail Pharmacy Market Outlook, by Application, 2020-2033
- 8.5.19. Rest of Middle East Retail Pharmacy Market Outlook, by End Use, 2020-2033
- 8.5.20. Rest of Middle East Retail Pharmacy Market Outlook, by Channel, 2020-2033
- 8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Walgreens Boots Alliance Inc.
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. CVS Health Corporation
- 9.4.3. Rite Aid Corporation
- 9.4.4. Walmart Inc.
- 9.4.5. Costco Wholesale Corporation
- 9.4.6. Kroger Co.
- 9.4.7. McKesson Corporation
- 9.4.8. Cardinal Health Inc.
- 9.4.9. AmerisourceBergen Corporation
- 9.4.10. Albertsons Companies
- 9.4.1. Walgreens Boots Alliance Inc.
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
샘플 요청 목록